Abstract:
The PhD thesis is centered on nanoengineering the bioavailability of Puerarin to
enhance its pharmacological potential. The first part provides a comprehensive
literature overview on natural compounds, with emphasis on flavonoids and modern
strategies for improving solubility and bioavailability. The second part presents
original contributions combining in silico investigations with experimental
development of PUE-based nanosystems and enzymatic derivatives. Computational
studies supported the prediction of biologically relevant activities, particularly
anticancer potential in the context of human melanoma and anti-inflammatory
relevance. In the nanotechnology section, greener PUE-assisted synthesis routes
were optimized for PUE–ZnO nanobiocomposites, PUE-Ag₂O/Ag and PUE-Ag
nanoparticles, and preliminary Cu/Ni/Fe-based systems, followed by
physicochemical and morphological characterization (XRD, UV-Vis, FTIR, SEM, TEM,
AFM, DLS, zeta potential) and biological evaluation (in vitro and in ovo). Proniosomal
gels were formulated as integrated niosome-based delivery systems for topical
administration of PUE, alongside preliminary biological testing. In the biocatalysis
section, enzymatic synthesis of PUE esters using natural acyl donors (hexanoic acid,
octanoic acid, vinyl laurate) was investigated in esterification and transesterification
systems. Reactions were optimized using immobilized lipase B from Candida
antarctica and further extended through original sol-gel entrapment immobilization
of Pseudomonas stutzerii lipase, yielding efficient formulations for PUE
transesterification. The thesis demonstrates that nanoengineering provide
complementary and sustainable strategies for improving the biopharmaceutical
properties of Puerarin for enabling the development of modern pharmaceutical
formulations.